Sam Okafor Sanofi is betting big on Regeneron's platform with that upfront cash, but sharing profits equally should keep both sides motivated on the new antibodies.
Elena Vasquez If Iran keeps testing Jordan's airspace, Washington needs to decide how far it's actually willing to go to back its allies in the region.